JPS6331446B2 - - Google Patents
Info
- Publication number
- JPS6331446B2 JPS6331446B2 JP57191820A JP19182082A JPS6331446B2 JP S6331446 B2 JPS6331446 B2 JP S6331446B2 JP 57191820 A JP57191820 A JP 57191820A JP 19182082 A JP19182082 A JP 19182082A JP S6331446 B2 JPS6331446 B2 JP S6331446B2
- Authority
- JP
- Japan
- Prior art keywords
- urease
- solution
- freeze
- activity
- nac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010046334 Urease Proteins 0.000 claims description 28
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 6
- 150000002016 disaccharides Chemical class 0.000 claims description 3
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 claims description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 1
- 229960004308 acetylcysteine Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 description 16
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 238000004108 freeze drying Methods 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 7
- 108010024636 Glutathione Proteins 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 229960003180 glutathione Drugs 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- -1 thiol compounds Chemical class 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940083618 sodium nitroprusside Drugs 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000007992 BES buffer Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57191820A JPS5982318A (ja) | 1982-11-02 | 1982-11-02 | 安定なウレア−ゼ製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57191820A JPS5982318A (ja) | 1982-11-02 | 1982-11-02 | 安定なウレア−ゼ製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5982318A JPS5982318A (ja) | 1984-05-12 |
| JPS6331446B2 true JPS6331446B2 (fr) | 1988-06-23 |
Family
ID=16281062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57191820A Granted JPS5982318A (ja) | 1982-11-02 | 1982-11-02 | 安定なウレア−ゼ製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5982318A (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200040323A1 (en) * | 2018-07-31 | 2020-02-06 | Fresenius Medical Care Holdings, Inc. | Urease Purification And Purified Urease Products Thereof And Sorbent Cartridges, Systems And Methods Using The Same |
-
1982
- 1982-11-02 JP JP57191820A patent/JPS5982318A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5982318A (ja) | 1984-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4409233A (en) | Highly concentrated preparations of dopa compounds | |
| PT88417B (pt) | Processo para a preparacao de composicoes farmaceuticas estabilizadas contendo uma proteina humana | |
| US3296094A (en) | Stabilized aqueous enzyme solutions | |
| US4188465A (en) | Stabilized urease composition | |
| Pan et al. | Comparative studies on methionine, selenomethionine, and their ethyl analogues as substrates for methionine adenosyltransferase from rat liver | |
| US4118279A (en) | Stabilizing agent for enzymes | |
| US2806815A (en) | Stabilized hyaluronidase | |
| Kirsch et al. | Evidence for conformational restrictions within the active site of acyl papains which influence the rates of hydrolysis | |
| US4046879A (en) | Antiviral compositions | |
| JPS6331446B2 (fr) | ||
| US9879250B2 (en) | Protein-stabilizing agent and protein-stabilizing method | |
| US2978385A (en) | Stabilized chymotrypsin solution | |
| JP3543144B2 (ja) | 臨床検査用製剤 | |
| US4235900A (en) | Cephradine compositions | |
| JPS6123995B2 (fr) | ||
| US3819487A (en) | Stable nadh compositions | |
| JPH0446558B2 (fr) | ||
| JPS6112675B2 (fr) | ||
| JP2008206491A (ja) | ｐ−ヒドロキシ安息香酸水酸化酵素の安定化方法 | |
| Whitner et al. | Stability of creatine kinase-3 in lyophilized materials. | |
| JPS59151899A (ja) | 測定用組成物 | |
| JPS6117467B2 (fr) | ||
| JPS60224499A (ja) | 安定なウリカ−ゼ製剤 | |
| JPS6231912B2 (fr) | ||
| US4219645A (en) | Stabilized nicotinamide-adenine dinucleotides and process for their preparation |